CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+9.84%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$15.7B
AUM Growth
+$15.7B
(+6.5%)
Cap. Flow
-$63.5M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
22.96%
Holding
929
New
41
Increased
265
Reduced
360
Closed
129
Top Buys
| 1 |
Eli Lilly
LLY
|
$106M |
| 2 |
PayPal
PYPL
|
$58.2M |
| 3 |
Hologic
HOLX
|
$46.2M |
| 4 |
Thermo Fisher Scientific
TMO
|
$36.7M |
| 5 |
Intuitive Surgical
ISRG
|
$34.3M |
Top Sells
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$79.5M |
| 2 |
Merck
MRK
|
$77.4M |
| 3 |
Apple
AAPL
|
$62.7M |
| 4 |
Verizon
VZ
|
$37.8M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$36M |
Sector Composition
| 1 | Healthcare | 31.3% |
| 2 | Technology | 26.69% |
| 3 | Financials | 8.86% |
| 4 | Communication Services | 7.82% |
| 5 | Consumer Discretionary | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CONE
226
DELISTED
CyrusOne Inc Common Stock
CONE
| $12.9M | 0.08% |
+131,624
| New | +$12.9M |
|
227
Oracle
ORCL
$635B
| $12.8M | 0.08% |
147,245
+16,618
| +13% | +$1.45M |
|
228
Louisiana-Pacific
LPX
$6.62B
| $12.8M | 0.08% |
163,735
-47,107
| -22% | -$3.69M |
|
229
Kura Oncology
KURA
$686M
| $12.7M | 0.08% |
907,433
-38,924
| -4% | -$545K |
|
230
Mersana Therapeutics
MRSN
$36.5M
| $12.6M | 0.08% |
2,022,895
| – | – |
|
231
American Tower
AMT
$95.5B
| $12.6M | 0.08% |
42,931
-45,013
| -51% | -$13.2M |
|
232
IBM
IBM
$227B
| $12.5M | 0.08% |
93,841
-24,556
| -21% | -$3.28M |
|
|
COHR
233
DELISTED
Coherent Inc
COHR
| $12.2M | 0.08% |
45,763
| – | – |
|
234
Zoetis
ZTS
$69.3B
| $12.1M | 0.08% |
49,667
-3,513
| -7% | -$857K |
|
235
Enanta Pharmaceuticals
ENTA
$180M
| $12.1M | 0.08% |
+161,358
| New | +$12.1M |
|
236
Shopify
SHOP
$184B
| $12.1M | 0.08% |
8,740
-6,572
| -43% | -$9.06M |
|
237
Intellia Therapeutics
NTLA
$1.22B
| $12M | 0.08% |
101,127
| – | – |
|
|
VG
238
DELISTED
Vonage Holdings Corporation
VG
| $11.9M | 0.08% |
+556,276
| New | +$11.9M |
|
239
Lam Research
LRCX
$127B
| $11.9M | 0.08% |
16,487
-13,003
| -44% | -$9.35M |
|
240
Moody's
MCO
$91.4B
| $11.8M | 0.08% |
30,310
-20
| -0.1% | -$7.81K |
|
241
DocuSign
DOCU
$15.5B
| $11.6M | 0.07% |
76,159
+18,400
| +32% | +$2.8M |
|
242
Mattel
MAT
$5.9B
| $11.5M | 0.07% |
535,016
+17,842
| +3% | +$385K |
|
243
Union Pacific
UNP
$133B
| $11.5M | 0.07% |
45,480
-18,922
| -29% | -$4.77M |
|
244
Zentalis Pharmaceuticals
ZNTL
$122M
| $11.5M | 0.07% |
136,226
-72,300
| -35% | -$6.08M |
|
245
Revolution Medicines
RVMD
$7.1B
| $11.3M | 0.07% |
450,382
-39,000
| -8% | -$982K |
|
246
Caterpillar
CAT
$196B
| $11.3M | 0.07% |
54,741
-3,147
| -5% | -$651K |
|
247
AT&T
T
$209B
| $11.1M | 0.07% |
451,573
-8,520
| -2% | -$210K |
|
248
Rogers Corp
ROG
$1.42B
| $11.1M | 0.07% |
+40,528
| New | +$11.1M |
|
249
Humana
HUM
$36.5B
| $11.1M | 0.07% |
23,845
+6,037
| +34% | +$2.8M |
|
250
Dollar General
DG
$23.9B
| $10.9M | 0.07% |
46,338
+2,447
| +6% | +$577K |
|